评估最近提出的用于定义肺量计支气管扩张剂反应的阈值。
Evaluation of recently proposed thresholds to define spirometry bronchodilator response.
作者信息
Hatic Elma, Färdig Martin, Amaral André F S, Jarvis Debbie, Accordini Simone, Bousquet Jean, Garcia-Aymerich Judith, Tan Wan C, Zuberbier Torsten, Janson Christer, Malinovschi Andrei
机构信息
Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
National Heart and Lung Institute, Imperial College London, London, UK.
出版信息
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.01162-2024. eCollection 2025 May.
Abstract
摘要
https://bit.ly/40wh723. （此为链接，无法准确翻译为中文，保留原文形式）
相似文献
1
Evaluation of recently proposed thresholds to define spirometry bronchodilator response.评估最近提出的用于定义肺量计支气管扩张剂反应的阈值。
ERJ Open Res. 2025 Jun 16;11(3). doi: 10.1183/23120541.01162-2024. eCollection 2025 May.
2
Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China.中国南方人群中支气管扩张剂反应对哮喘的诊断准确性。
Adv Ther. 2018 Oct;35(10):1578-1584. doi: 10.1007/s12325-018-0783-0. Epub 2018 Sep 12.
3
Prevalence of Bronchodilator Responsiveness: A Comparison of Old Versus New Criteria.支气管扩张剂反应性的流行率：新旧标准的比较。
Respir Care. 2024 Sep 26;69(10):1266-1274. doi: 10.4187/respcare.11603.
4
Effect of extending the time after bronchodilator administration on identifying bronchodilator responsiveness in a pediatric pulmonary clinic.支气管扩张剂给药后延长时间对儿科肺病门诊中支气管扩张剂反应性识别的影响。
Pediatr Pulmonol. 2017 Aug;52(8):984-989. doi: 10.1002/ppul.23752. Epub 2017 Jul 3.
5
Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.支气管扩张剂测试的临床意义：诊断与鉴别慢性阻塞性肺疾病和哮喘-慢性阻塞性肺疾病重叠综合征
Respir Care. 2022 Apr;67(4):440-447. doi: 10.4187/respcare.09215.
6
Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.慢性阻塞性肺疾病稳定期的诊断与管理：美国医师学会、美国胸科学会、美国胸科学会和欧洲呼吸学会的临床实践指南更新。
Ann Intern Med. 2011 Aug 2;155(3):179-91. doi: 10.7326/0003-4819-155-3-201108020-00008.
7
Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults.现行的支气管扩张剂反应性标准低估了老年人的哮喘情况。
Respir Care. 2020 Aug;65(8):1104-1111. doi: 10.4187/respcare.07132. Epub 2020 Feb 18.
8
Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.2021年欧洲呼吸学会（ERS）/美国胸科学会（ATS）肺功能测试解读新指南对气道阻塞患者支气管扩张剂反应性解读的影响
Respir Med. 2023 Dec;220:107460. doi: 10.1016/j.rmed.2023.107460. Epub 2023 Nov 9.
9
Argument for changing criteria for bronchodilator responsiveness.关于改变支气管扩张剂反应性标准的论据。
Respir Med. 2008 Dec;102(12):1777-83. doi: 10.1016/j.rmed.2008.06.019. Epub 2008 Aug 12.
10
Assessing the Impact of the Updated 2021 European Respiratory Society/American Thoracic Society Criteria on Bronchodilator Responsiveness in Asthma.评估2021年更新的欧洲呼吸学会/美国胸科学会标准对哮喘患者支气管扩张剂反应性的影响。
Cureus. 2024 Aug 14;16(8):e66844. doi: 10.7759/cureus.66844. eCollection 2024 Aug.
引用本文的文献
1
Assessment of Bronchodilator Response in Patients with CF and Non-CF Bronchiectasis-A Randomized Controlled Study.囊性纤维化和非囊性纤维化支气管扩张患者支气管扩张剂反应的评估——一项随机对照研究
J Clin Med. 2025 Jul 7;14(13):4778. doi: 10.3390/jcm14134778.
本文引用的文献
1
Assessing the Impact of the Updated 2021 European Respiratory Society/American Thoracic Society Criteria on Bronchodilator Responsiveness in Asthma.评估2021年更新的欧洲呼吸学会/美国胸科学会标准对哮喘患者支气管扩张剂反应性的影响。
Cureus. 2024 Aug 14;16(8):e66844. doi: 10.7759/cureus.66844. eCollection 2024 Aug.
2
Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD.在初治哮喘和慢性阻塞性肺疾病（COPD）患者中，使用不同标准评估沙丁胺醇或异丙托溴铵的支气管扩张剂反应性。
Eur Clin Respir J. 2024 Mar 21;11(1):2328434. doi: 10.1080/20018525.2024.2328434. eCollection 2024.
3
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.支气管舒张剂反应性的流行率、诊断效用及相关特征。
Am J Respir Crit Care Med. 2024 Feb 15;209(4):390-401. doi: 10.1164/rccm.202308-1436OC.
4
Impact of the new European respiratory (ERS)/American Thoracic Society (ATS) pulmonary function test interpretation guidelines 2021 on the interpretation of bronchodilator responsiveness in subjects with airway obstruction.2021年欧洲呼吸学会（ERS）/美国胸科学会（ATS）肺功能测试解读新指南对气道阻塞患者支气管扩张剂反应性解读的影响
Respir Med. 2023 Dec;220:107460. doi: 10.1016/j.rmed.2023.107460. Epub 2023 Nov 9.
5
The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort.2022年欧洲呼吸学会/美国胸科学会支气管扩张剂反应新推荐：与哮喘队列中先前版本的比较
Arch Bronconeumol. 2023 Sep;59(9):608-611. doi: 10.1016/j.arbres.2023.05.015. Epub 2023 Jun 1.
6
Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.支气管扩张剂反应性的定义：2005 年和 2021 年 ERS/ATS 标准在哮喘以及慢性阻塞性肺疾病患者中的应用。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 17;17:2623-2633. doi: 10.2147/COPD.S385733. eCollection 2022.
7
European Respiratory Society guidelines for the diagnosis of asthma in adults.欧洲呼吸学会成人哮喘诊断指南。
Eur Respir J. 2022 Sep 7;60(3). doi: 10.1183/13993003.01585-2021. Print 2022 Sep.
8
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准：常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
9
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
10
Bronchodilator reversibility in asthma and COPD: findings from three large population studies.支气管扩张剂在哮喘和 COPD 中的可逆性：三项大型人群研究的结果。
Eur Respir J. 2019 Sep 5;54(3). doi: 10.1183/13993003.00561-2019. Print 2019 Sep.
Zotero 插件